Cargando…

Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles

Global people are suffering from the legion of diseases. Cytotoxic property of the chemical compound would not solely influence effective drug properties and reduce unnecessary side effects. Proteins/enzymes responsible for microbe proliferation or survival are specifically targeted and inhibited su...

Descripción completa

Detalles Bibliográficos
Autor principal: Dorababu, Atukuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132078/
https://www.ncbi.nlm.nih.gov/pubmed/32274429
http://dx.doi.org/10.1016/j.heliyon.2020.e03656
_version_ 1783517378452127744
author Dorababu, Atukuri
author_facet Dorababu, Atukuri
author_sort Dorababu, Atukuri
collection PubMed
description Global people are suffering from the legion of diseases. Cytotoxic property of the chemical compound would not solely influence effective drug properties and reduce unnecessary side effects. Proteins/enzymes responsible for microbe proliferation or survival are specifically targeted and inhibited successfully making the cells to undergo apoptosis. Furthermore, isoforms of essential enzymes have distinct physiological functions; thereby inhibition of essential enzyme isoforms is an apt way to the clinical approach of disease neutralization. Drugs are designed so as to play significant roles such as signaling pathways in the oncogenic process including cell proliferation, invasion, and angiogenesis. The present review comprises collective information of the recent synthesis of various organic drug compounds in brief, which could inhibit particular enzyme. The review also covers the correlation of the structure of a drug molecule designed and its inhibitory activity. Also, the most significant enzyme inhibitors are highlighted and structural moieties/core units responsible for remarkable inhibitory values are emphasized.
format Online
Article
Text
id pubmed-7132078
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-71320782020-04-09 Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles Dorababu, Atukuri Heliyon Article Global people are suffering from the legion of diseases. Cytotoxic property of the chemical compound would not solely influence effective drug properties and reduce unnecessary side effects. Proteins/enzymes responsible for microbe proliferation or survival are specifically targeted and inhibited successfully making the cells to undergo apoptosis. Furthermore, isoforms of essential enzymes have distinct physiological functions; thereby inhibition of essential enzyme isoforms is an apt way to the clinical approach of disease neutralization. Drugs are designed so as to play significant roles such as signaling pathways in the oncogenic process including cell proliferation, invasion, and angiogenesis. The present review comprises collective information of the recent synthesis of various organic drug compounds in brief, which could inhibit particular enzyme. The review also covers the correlation of the structure of a drug molecule designed and its inhibitory activity. Also, the most significant enzyme inhibitors are highlighted and structural moieties/core units responsible for remarkable inhibitory values are emphasized. Elsevier 2020-04-02 /pmc/articles/PMC7132078/ /pubmed/32274429 http://dx.doi.org/10.1016/j.heliyon.2020.e03656 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Dorababu, Atukuri
Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles
title Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles
title_full Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles
title_fullStr Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles
title_full_unstemmed Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles
title_short Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles
title_sort synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132078/
https://www.ncbi.nlm.nih.gov/pubmed/32274429
http://dx.doi.org/10.1016/j.heliyon.2020.e03656
work_keys_str_mv AT dorababuatukuri synthesispharmacologicalevaluationandstructureactivityrelationshipofrecentlydiscoveredenzymeantagonistazoles